Story · Medicine & Biotech

Neeraj Agarwal: FDA Approval of EV Plus Durvalumab Opens a New Chapter in MIBC

1 outlet · first reported by OncoDaily on

Neeraj Agarwal, Co-Director of Prostate Cancer Program at Dana-Farber Cancer Institute, shared on X: “FDA approves durvalumab + enfortumab vedotin-ejfv for muscle invasive bladder cancer today based on ph3 Volga (OncoDaily)

Coverage, in order

  1. OncoDaily obscure study
    Neeraj Agarwal: FDA Approval of EV Plus Durvalumab Opens a New Chapter in MIBC

    Neeraj Agarwal, Co-Director of Prostate Cancer Program at Dana-Farber Cancer Institute, shared on X: “FDA approves durvalumab + enfortumab vedotin-ejfv for muscle invasive bladder cancer today based on ph3 Volga

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.